ATI LPN
Pharmacology and the Nursing Process 10th Edition Test Bank
Chapter 34 : Women?s Health Drugs Questions
Question 1 of 5
An older adult female patient is receiving the progestin drug megestrol. Which is the most likely reason megestrol is ordered for this patient?
Correct Answer: C
Rationale: Megestrol is used as an appetite stimulant in conditions like cancer or AIDS-related cachexia. It is not indicated for migraines, osteoporosis, or hot flashes.
Question 2 of 5
The nurse is providing patient education for a patient taking an oral contraceptive. Which drugs may cause interactions with oral contraceptives? (Select all that apply.)
Correct Answer: A,C,E
Rationale: Cephalexin, warfarin, and theophylline can interact with oral contraceptives, reducing their efficacy or altering drug levels. Antibiotics like cephalosporins may decrease contraceptive effectiveness, and contraceptives can affect warfarin and theophylline metabolism.
Question 3 of 5
A patient is to receive medroxyprogesterone (Depo-Provera) 700 mg weekly, intramuscularly, as part of palliative therapy for endometrial cancer. The medication is available in vials of 400 mg/mL. Identify how many milliliters will the nurse draw up and administer with each injection. (record answer using one decimal place)
Correct Answer: 1.8 mL
Rationale:
To calculate: 400 mg/1 mL = 700 mg/x mL. Cross-multiply: (400 * x) = (1 * 700); 400x = 700; x = 700/400 = 1.75 mL, rounded to 1.8 mL.
Question 4 of 5
The nurse is providing teaching for a patient who is to receive progestin therapy. Which statement is correct to include in the teaching session?
Correct Answer: C
Rationale: Significant weight gain (5 pounds or more per week) during progestin therapy may indicate fluid retention or other adverse effects, requiring medical evaluation. Doubling doses, ignoring breast lumps, or taking on an empty stomach are incorrect.
Question 5 of 5
The nurse recognizes that use of estrogen drugs is contraindicated in which patient?
Correct Answer: D
Rationale: Estrogen increases the risk of thromboembolism, making it contraindicated in patients with a history of thrombophlebitis. Atrophic vaginitis and inoperable prostate cancer are indications for estrogen therapy, and it is not used to prevent lactation.